German Law Has Companies Weighing Whether to Sell New Drugs in Europe's Largest Market
The Burrill Report spoke to Achim Diedenhofen, Founder and former Partner of the consulting firm Executive Insight, about the new law, what it means to pharmaceutical revenues, and how companies will need to think about rolling out their drugs in Europe going forward.
